Ozempic carries a list price of roughly $935 to $1,028 per month, depending on the dose. That’s the sticker price before insurance, coupons, or pharmacy discounts. What you actually pay can range from as little as $25 a month with commercial insurance and a savings card to the full list price if you’re uninsured or paying out of pocket.
List Price by Dose
Novo Nordisk, the company that makes Ozempic, sets the same list price regardless of which pen strength you use. Whether you’re on the 0.25 mg starter dose, the 0.5 mg dose, the 1 mg dose, or the 2 mg dose, each pen costs $935 to $1,028. The exact number can shift slightly with periodic wholesale price adjustments, but the prices across doses stay uniform. This means stepping up to a higher dose during treatment doesn’t increase your monthly cost at the list-price level.
Each pen is designed to deliver four weekly injections (a one-month supply). Once you open a pen, it stays usable for 56 days whether you store it in the refrigerator or at room temperature. After 56 days, the pen should be discarded even if medication remains inside.
What You Pay With Insurance
Most commercial insurance plans cover Ozempic when it’s prescribed for type 2 diabetes, which is its primary FDA-approved use. Your copay depends on your plan’s formulary tier and deductible structure. Many people with commercial coverage pay between $25 and $150 a month after insurance kicks in.
Novo Nordisk also offers a manufacturer savings card that can bring your copay down to as little as $25 per month for commercially insured patients. The card caps savings at $100 per fill and remains valid for up to 48 months. To qualify, you need to be at least 18, a U.S. resident, and covered by a commercial (private) insurance plan that already includes Ozempic.
A few important details on eligibility: people enrolled in Medicare, Medicaid, Tricare, or any other government-funded insurance program cannot use the savings card. However, those on Federal Employees Health Benefits (FEHB) plans, Affordable Care Act marketplace plans, or state employee plans are considered commercially insured and can use it.
Paying Without Insurance
Without insurance, you’re looking at roughly $935 to $1,028 per month at a retail pharmacy. Some people reduce that through pharmacy discount programs like GoodRx or RxSaver, which can occasionally bring the cash price down by a modest percentage, though Ozempic discounts tend to be smaller than for generic medications. Canadian and international pharmacies sometimes offer lower prices, but importing prescription drugs carries legal and safety considerations.
Novo Nordisk runs a patient assistance program for people without insurance who meet income requirements. If you qualify, you may receive Ozempic at no cost. The application process typically requires proof of income and a prescription from your provider.
How Dosing Affects Total Cost
Ozempic treatment follows a gradual dose increase. You start at 0.25 mg once a week for four weeks. That starter dose isn’t meant to control blood sugar on its own; it lets your body adjust to the medication and reduces side effects like nausea. After four weeks, you move up to 0.5 mg weekly. If more blood sugar control is needed after at least another four weeks, your provider may increase the dose to 1 mg or eventually 2 mg per week.
Because the list price is the same across all pen strengths, your out-of-pocket cost generally stays flat as you titrate up. You’re still using one pen per month at every stage. The main cost variable isn’t the dose but how your insurance plan handles coverage and what tier the drug sits on.
How Ozempic Compares to Wegovy
Ozempic and Wegovy contain the same active ingredient, semaglutide, but they’re approved for different purposes. Ozempic is FDA-approved for type 2 diabetes and cardiovascular risk reduction. Wegovy is approved for chronic weight management in people with obesity or who are overweight with at least one weight-related health condition.
Wegovy’s list price runs slightly higher, around $1,300 to $1,350 per month depending on the dose. Insurance coverage also differs significantly between the two. Many health plans cover Ozempic under their diabetes formulary but exclude or restrict Wegovy because weight management drugs historically receive less insurance coverage. If your provider prescribes Ozempic off-label for weight loss, your insurer may deny coverage since the prescription doesn’t match the drug’s approved indication.
Why Coverage Can Be Denied
Even with insurance, Ozempic coverage isn’t guaranteed. Plans may require prior authorization, meaning your provider needs to submit documentation proving you meet specific criteria, typically a type 2 diabetes diagnosis and evidence that other treatments were tried first. Some insurers place Ozempic on a higher formulary tier with steeper copays, or they may prefer a competing medication in the same drug class and require you to try that one before approving Ozempic.
If your claim is denied, your provider can usually file an appeal. The most common reason for denial is a missing prior authorization or an off-label use like weight loss without a diabetes diagnosis. Getting the paperwork right on the first submission saves weeks of back-and-forth.